Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
Public ClinicalTrials.gov record NCT02462837. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The objective of this pilot study is to assess whether Myrbetriq™ will improve post-operative ureteral pain and discomfort, reduce bladder storage symptoms and increase quality of life following ureteral stenting.
Study identification
- NCT ID
- NCT02462837
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 11 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2015
- Primary completion
- Jan 29, 2019
- Completion
- Jan 29, 2019
- Last update posted
- Jun 12, 2023
2015 – 2019
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| SIUSOM - Division of Urology | Springfield | Illinois | 62794-9665 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Urinary Bladder, Overactive trials
Other public records listing Urinary Bladder, Overactive. Sorted by last update posted; newest first. Not a recommendation.
- NCT06336304: NXT Post-Market Clinical Follow-up Recruiting
- NCT07425015: Ambulatory Long Length URodynamics Evaluation Recruiting
- NCT05250908: INTIBIA Pivotal Study Active, not recruiting
- NCT05715268: Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study Active, not recruiting
- NCT07387315: A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Not yet recruiting
- NCT05880862: Comparative Effectiveness of Initial OAB Treatment Options Among Older Women at High Risk of Falls Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02462837, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 12, 2023 · Synced Sep 9, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02462837 live on ClinicalTrials.gov.